Pharmaceuticals
Eris Lifesciences Ltd: Key Risks for Investors
Eris Lifesciences Ltd is an Indian pharmaceutical company primarily focused on the domestic branded formulations market. The company mainly deals in chronic and sub-chronic therapeutic areas such as diabetes, cardiac care, and dermatology. It relies heavily on prescriptions from medical specialists and super-specialists primarily in
Analysis: Senores Pharmaceuticals Ltd
The current section of the “Analysis” series covers Senores Pharmaceuticals Ltd, an Indian pharmaceutical company focusing primarily on the regulated markets of the USA, UK and Canada. The company also has a smaller presence in India and other emerging pharmaceutical markets. Please note that to
Analysis: Titan Biotech Ltd
The current section of the “Analysis” series covers Titan Biotech Ltd, an Indian company engaged in the manufacturing of biotechnology products such as protein hydrolysates, collagen, peptones and dehydrated culture media. Please note that to get maximum benefit from this article, an investor should focus
Analysis: Abbott India Ltd
The current section of the “Analysis” series covers Abbott India Ltd, a part of Abbott Group, USA. The company is a leading pharmaceutical company in India with leading brands like Thyronorm, Digene, Cremafin, Brufen, and Duphaston among many others. To benefit the maximum from this
Analysis: Dr Reddy’s Laboratories Ltd
The current section of the “Analysis” series covers Dr Reddy’s Laboratories Ltd (DRL), a leading Indian pharmaceutical company with global operations across North America, Europe, Russia, South America and the rest of the world. DRL has products in generics, active pharmaceutical ingredients (APIs), custom products,
Analysis: Laurus Labs Ltd
The current section of the “Analysis” series covers Laurus Labs Ltd, an Indian pharmaceutical company focusing on the production of APIs, formulations as well as the custom synthesis of drugs in antiretroviral (HIV), Oncology, Hepatitis-C, Diabetes, Cardiovascular diseases etc. “Analysis” series is an attempt to
How to do Business Analysis of Pharmaceutical Companies
The current article aims to cover the key factors affecting the business model of pharmaceutical (pharma) companies. After reading this article, an investor would be able to differentiate pharmaceutical companies based on the strength of their business model. She would be able to have an
Analysis: NGL Fine Chem Ltd
The current section of the “Analysis” series covers NGL Fine Chem Ltd, an Indian manufacturer of active pharmaceutical ingredients (API) primarily for animal drugs. “Analysis” series is an attempt to share with all the readers, our inputs to the company analysis submitted by readers on
Analysis: Lincoln Pharmaceuticals Ltd
The current section of the “Analysis” series covers Lincoln Pharmaceuticals Ltd, an Indian company manufacturing pharmaceutical formulations. The company sells its products primarily in India and African nations. “Analysis” series is an attempt to share with all the readers, our inputs to the company analysis
Analysis: Marksans Pharma Ltd
The current section of the “Analysis” series covers Marksans Pharma Ltd, an Indian drug manufacturer selling generic drugs primarily in the developed markets of the USA, UK, Europe and Australia. The company has production facilities in Goa, India as well as in the UK and
- Buy/sell recommendations for selected stocks with a crisp investment rationale
- We have selected these stocks after an in-depth financial, business, valuation, and management analysis
“Peaceful Investing” is the result of my experience of about 20 years in stock markets. It aims to find such stocks, where after investing, an investor may sleep peacefully. If later on, the stock prices increase, then the investor is happy as she is now wealthier. If the stock prices decline, even then the investor is happy as she can now buy more quantity of the selected fundamentally good stocks.


Sign up to get updates
+ Get 12 free e-books on Stock Analysis